Issued Patents 2022
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11530267 | Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof | Kent B. Thudium, Kyra D. Zens, Mark Yamanaka, Alan J. Korman, Heidi N. LeBlanc | 2022-12-20 |
| 11529399 | Anti-ICOS agonist antibodies and uses thereof | John J. ENGELHARDT, Alan J. Korman, Mary Diane Feingersh, Brenda L. Stevens | 2022-12-20 |
| 11512130 | Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof | Kent B. Thudium, Kyra D. Zens, Mark Yamanaka, Alan J. Korman, Heidi N. LeBlanc | 2022-11-29 |
| 11408889 | Anti-GITR antibodies for cancer diagnostics | Xi-Tao Wang, Olufemi A. Adelakun, Anne C. Lewin, Alan J. Korman, Changyu Wang +10 more | 2022-08-09 |
| 11401328 | Antibodies binding to ILT4 | Xiao Min Schebye, Diana Yuhui Chen, Andrew Rankin, Xiaodi Deng, Joseph Toth +9 more | 2022-08-02 |
| 11306143 | Combination of TIM-4 antagonist and PD-1 antagonist and methods of use | Sean Doyle, Eric M. Chadwick | 2022-04-19 |
| 11274152 | Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors | Alan J. Korman, Nils Lonberg, David J. FONTANA, Andres A. GUTIERREZ, Katherine E. Lewis | 2022-03-15 |
| 11236165 | Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereof | Kent B. Thudium, Kyra D. Zens, Mark Yamanaka, Alan J. Korman, Heidi N. LeBlanc | 2022-02-01 |
| 11236164 | Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof | Kent B. Thudium, Kyra D. Zens, Mark Yamanaka, Alan J. Korman, Heidi N. LeBlanc | 2022-02-01 |
| 11236163 | Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof | Kent B. Thudium, Kyra D. Zens, Mark Yamanaka, Alan J. Korman, Heidi N. LeBlanc | 2022-02-01 |
| 11213586 | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) | Changyu Wang, Nils Lonberg, Alan J. Korman, Mohan Srinivasan, Karla A. HENNING +13 more | 2022-01-04 |